Manufacturing

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

Yimmugo, which was introduced in Europe at the end of 2022, could be on the market in the US within months.

FDA Approves Immunoglobulin Therapeutic to Treat Primary Immunodeficiencies

Videos

Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the important components of nitrosamine impurities from a manufacturing point of view as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."

Crucial Points from a Manufacturing Perspective (PDA/FDA Joint Regulatory Conference 2023)

Sander Van Gessel, MEng, Business Unit Director, DFE Pharma, discusses the recent findings of nitrosamine impurities in human drugs as a part of his session, "Reducing Nitrosamines Without the Use of Scavengers: The Critical Role of Excipients - An Excipient Manufacturer's View."

The Recent Discoveries of Nitrosamine Impurities (PDA/FDA Joint Regulatory Conference 2023)

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.

ten23 Expands Sterile Manufacturing Capacity at VIVA 1 Facility 

There are many promising trials in the pipeline that may bring big news for major therapeutic areas.

Clinical Trials and their Impact on the Pharma Industry

Twist Bioscience is a synthetic biology and genomics company that has developed a DNA synthesis platform to industrialize the engineering of biology, which is a new method of this process by “writing” DNA on a silicon chip.

Ono Pharmaceutical Enters Drug Discovery Collaboration Agreement with Twist Bioscience

There are solutions on the horizon that will help overcome the current bottlenecks and other challenges that are occurring in early drug development.

Moving Closer to Dynamic Drug Development through Automated Solutions

The new method was developed to isolate tissue-specific EVs from the blood in addition to using a workflow to analyze their diverse multi-omics content. 

Mursla Bio Discovers New Biomarker Approach in Precision Medicine

The first CleanCap analog was launched in 2017, and since then, the capping technology has been incorporated in one of the first commercially approved COVID-19 vaccines.

TriLink Biotechnologies Introduces CleanCap M6 Analog

According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.

Manufacturing, Drug Products